3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
36
Neoplasms, Plasma Cell
12
Prostatic Neoplasms
4
Neoplasms
3
Lymphoma, Mantle-Cell
3
Immunoglobulin Light-chain Amyloidosis
3
Central Nervous System Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Neuroblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Glioblastoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Amyloidosis
2
Adenocarcinoma of Lung
2
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Polyneuropathies
1
Paraproteinemias
1
Neurotoxicity Syndromes
1
Motor Activity
1
Interventions
Sunitinib
16
Imatinib Mesylate
13
nilotinib
8
ripretinib
4
regorafenib
4
avapritinib
3
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
3
pexidartinib
2
pembrolizumab
2
Bevacizumab
2
trametinib
1
tinostamustine
1
spartalizumab
1
romidepsin
1
ponatinib
1
pazopanib
1
palbociclib
1
olaratumab
1
guadecitabine
1
ferric carboxymaltose
1
epacadostat
1
dabrafenib
1
cediranib
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sorafenib
1
STA 9090
1
Observation
1
Iron-Dextran Complex
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Stromal Tumors
×
Thalidomide
×
Clear all
No trials found.